Skip to main content
. 2006 Spring;11(1):11–38. doi: 10.1155/2006/642568

TABLE 8.

Analgesic antidepressants

Neurotransmitter profile
Most common side effects (%)
Drug Common trade name Therapeutic range for pain (mg/24 h) Half-life (h) NA 5-HT Sedation Orthostatic hypotension Weight gain Dry mouth Constipation GI distress, nausea, diarrhea
Tricyclics
Amitriptyline Elavil 10–150* 10–46 +++ +++ >30 >10 >30 >30 >10 >2
Doxepin Sinequan 10–150* 8–36 +++ ++ >30 >10 >10 >30 >10 <2
Trimipramine Surmontil§ 10–150* 7–30 ++ + >30 >10 >10 >10 >10 <2
Imipramine Tofranil 10–150* 4–34 +++ +++ >10 >30 >10 >30 >10 >10
Clomipramine Anafranil** 10–150* 17–37 +++ ++++ >2 >10 >10 >30 >10 >10
Desipramine Norpramin§ 10–150* 12–76 +++++ ++ >2 >2 >2 >10 >2 >2
Nortriptyline Aventyl†† 10–100* 13–88 ++++ ++ >2 >2 >2 >10 >10 <2
Serotonin/noradrenaline reuptake inhibitors
Venlafaxine Effexor‡‡ 37.5–225 3–7 (parent)
9–13 (metabolite)
++ ++++ >10 >10 <2 >10 >10 >30
Duloxetine Cymbalta§§ 60–120 10 ++++ +++++ >10 <10 <2 >10 >10 >10
*

The therapeutic range for depression is up to 200 mg/24 h for nortriptyline and to 300 mg/24 h for the remaining tricyclic antidepressants; generally, these doses are not required for an analgesic effect and the usual dose will consist of 75 mg/24 h or less;

1560678 Ontario Inc, Canada;

ERFA Canada Inc;

§

Aventis Pharma Inc, Canada;

Novartis Pharmaceuticals, Canada;

**

Oryx Pharmaceuticals Inc, Canada;

††

Pharmel Inc, Canada;

‡‡

Wyeth Canada;

§§

Lilly, USA. 5-HT 5-Hydroxytryptamine; GI Gastrointestinal; NA Noradrenaline. Adapted from reference 286